MabCure Inc.
MabCure is a biotechnology company whose vision is to change the perception of cancer as a largely incurable disease. MabCure's primary mission is to develop novel diagnostics for the early detection of cancer when the disease is still localized and treatable, and where the chances for cure are greater than 90 percent.
MabCure’s longer term goals are to provide physicians with novel antibodies and drugs that effectively attack only cancer cells while sparing normal tissue and minimize toxic side effects.
See President & CEO, Dr. Amnon Gonenne, talk about MabCure and its technology.